Overview
NUCOR CORP
Latest 10-K: FY2025, filed Feb 25, 2026 · Open the 10-K (Inline XBRL) ↗
- Revenue
- $32.49B
- 5.7%YoYup from FY2024
- TotalRevenue
- Gross profit
- $3.88B
- 5.5%YoYdown from FY2024
- GrossProfit
- Net income
- $1.74B
- 14.0%YoYdown from FY2024
- NetIncome
- Diluted EPS
- $7.52
- 11.1%YoYdown from FY2024
- EPSDiluted
- Diluted shares
- 231.0M
- 3.1%YoYdown from FY2024
- WeightedAvgSharesDiluted
At a glance
Growth
- NUCOR CORP reported revenue of $32.49B for fiscal 2025, up 5.7% from fiscal 2024.
- Revenue grew faster than the median S&P 500 member in 2 of the last 5 fiscal years.
Profitability
- Net margin was 5.4%, against a median of 12.8% across S&P 500 members for the same fiscal year.
Per share
- Diluted EPS was $7.52, down 11.1% from the prior year.
Written from the filed figures on this page by fixed rules — no AI.
Data as of Nov 2, 2026 · Sources: SEC EDGAR 10-K
Financial statements
Annual figures from the 10-K, most recent fiscal year first.
Income Statement
5 annual periodsChip: YoY change.
| Line item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | 4Y CAGR |
|---|---|---|---|---|---|---|
| Revenue | $32.49B5.7%up Benchmark median 6.4% | $30.73B11.5%down Benchmark median 4.5% | $34.71B16.4%down Benchmark median 4.8% | $41.51B13.8%up Benchmark median 10.3% | $36.48B81.2%up Benchmark median 13.8% | -2.9% Benchmark median 6.6% |
| Gross Profit Median of 315 / 498 | $3.88B5.5%down Benchmark median 6.8% | $4.10B47.5%down Benchmark median 5.5% | $7.82B37.5%down Benchmark median 5.2% | $12.50B13.4%up Benchmark median 8.3% | $11.03B394.9%up Benchmark median 15.7% | -23.0% Benchmark median 6.2% |
| Operating Income Median of 373 / 498 | — | — | — | — | — | — Benchmark median 7.2% |
| Net Income | $1.74B14.0%down Benchmark median 4.8% | $2.03B55.2%down Benchmark median 5.7% | $4.53B40.5%down Benchmark median 1.9% | $7.61B11.4%up Benchmark median 1.3% | $6.83B846.3%up Benchmark median 33.9% | -28.9% Benchmark median 4.1% |
| EPS (Diluted) | $7.5211.1%down Benchmark median 6.2% | $8.4653.0%down Benchmark median 7.9% | $18.0037.5%down Benchmark median 1.9% | $28.7924.3%up Benchmark median 1.5% | $23.16881.4%up Benchmark median 34.8% | -24.5% Benchmark median 5.6% |
Balance Sheet
5 annual periodsChip: YoY change.
| Line item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | 4Y CAGR |
|---|---|---|---|---|---|---|
| Total Assets | $35.10B3.4%up Benchmark median 5.6% | $33.94B4.0%down Benchmark median 3.4% | $35.34B8.8%up Benchmark median 4.1% | $32.48B25.8%up Benchmark median 2.2% | $25.82B28.3%up Benchmark median 6.7% | 8.0% Benchmark median 4.7% |
| Total Liabilities Median of 357 / 498 | $12.98B3.6%up Benchmark median 6.4% | $12.52B5.3%down Benchmark median 1.9% | $13.22B2.4%up Benchmark median 2.9% | $12.91B15.1%up Benchmark median 2.0% | $11.22B26.2%up Benchmark median 5.2% | 3.7% Benchmark median 4.4% |
| Stockholders' Equity | $22.12B3.3%up Benchmark median 6.8% | $21.42B3.2%down Benchmark median 5.4% | $22.12B13.0%up Benchmark median 7.3% | $19.57B34.0%up Benchmark median 2.5% | $14.60B30.0%up Benchmark median 9.0% | 10.9% Benchmark median 6.1% |
| Cash & Equivalents | $2.26B36.5%down Benchmark median 5.2% | $3.56B44.3%down Benchmark median 1.9% | $6.38B49.1%up Benchmark median 6.7% | $4.28B81.0%up Benchmark median -8.6% | $2.36B10.4%down Benchmark median -2.9% | -1.1% Benchmark median 2.0% |
| Total Debt | $7.10B2.4%up Benchmark median 2.1% | $6.93B1.5%up Benchmark median 0.2% | $6.83B2.3%up Benchmark median 0.3% | $6.67B17.7%up Benchmark median 0.1% | $5.67B6.2%up Benchmark median -0.1% | 5.8% Benchmark median 4.3% |
Cash Flow Statement
5 annual periodsChip: YoY change.
| Line item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | 4Y CAGR |
|---|---|---|---|---|---|---|
| Operating Cash Flow | $3.23B18.7%down Benchmark median 6.3% | $3.98B44.1%down Benchmark median 4.8% | $7.11B29.4%down Benchmark median 9.9% | $10.07B61.6%up Benchmark median -0.7% | $6.23B131.0%up Benchmark median 10.7% | -15.1% Benchmark median 7.0% |
| Capital Expenditures | $3.42B7.8%up Benchmark median 5.4% | $3.17B43.3%up Benchmark median 2.8% | $2.21B13.7%up Benchmark median 11.3% | $1.95B20.1%up Benchmark median 14.0% | $1.62B5.1%up Benchmark median 8.1% | 20.5% Benchmark median 9.0% |
| Free Cash Flow Median of 378 / 498 | negative: -$0.19B123.3%down Benchmark median 7.3% | $0.81B83.5%down Benchmark median 6.1% | $4.90B39.7%down Benchmark median 8.8% | $8.12B76.3%up Benchmark median -11.3% | $4.61B299.5%up Benchmark median 10.2% | n/m Benchmark median 4.9% |
n/m: not meaningful — the base (the prior year, or the first year for the CAGR) was zero or negative, or a per-share figure’s share basis changed (stock split). “—” means the figure is not available.
Benchmark median = median of the companies in the S&P 500 on Dec 31 of each fiscal year, from their own 10-K filings; a change counts only companies whose prior year was positive. Each median uses every member that reports the line item; where fewer than 80% do (banks and insurers file no gross profit), the row names how many. Published where at least 250 companies report it. Updated 2026-10-27. This compares reported figures, not share-price returns. Methodology
Ratios & valuation
FY2025Every ratio read two ways: Wall Street’s popular formula and the value investor’s stricter one. Same question, same unit. Pick a ratio.
Valuation · Earnings yield
What a dollar of market value earned
4.6%
Wall Street
on net earnings
FY2024 7.2%
negative: −0.5%
Value investor
on free cash flow
FY2024 2.9%
Gap −5.1 pts: Value-investor figure 5.1 points lower
How it’s calculated
Wall Street · on net earnings
Diluted EPS ÷ fiscal-year-end share price (1 ÷ P/E)
pe_ratio (ratio table)
P/E 21.7×Value investor · on free cash flow
(Operating cash flow − capital expenditures) ÷ market capitalisation (fiscal-year-end close × weighted-average diluted shares)
free cash flow ÷ market cap
Valuation · Book yield
Net assets behind a dollar of market value
58.7%
Wall Street
on book equity
FY2024 76.9%
47.3%
Value investor
on tangible book
FY2024 61.5%
Gap −11.4 pts: Value-investor figure 11.4 points lower
How it’s calculated
Wall Street · on book equity
Book value of equity ÷ market capitalisation (1 ÷ P/B)
pb_ratio (ratio table)
P/B 1.7×Value investor · on tangible book
Tangible book value (equity less goodwill and intangibles) ÷ market capitalisation
tangible_book_value_per_share ÷ (pb_ratio × book_value_per_share)
Quality · Return on capital
Profit earned on the money in the business
8.0%
Wall Street
ROE: net income ÷ equity
FY2024 9.3%
— Not reported
Value investor
ROIC: after-tax operating profit ÷ invested capital
FY2024 — Not reported
How it’s calculated
Wall Street · ROE: net income ÷ equity
Net income ÷ average stockholders' equity (start and end of year), including noncontrolling interests. Buybacks shrink equity and lift it.
return_on_equity (ratio table)
Value investor · ROIC: after-tax operating profit ÷ invested capital
Operating profit after tax ÷ invested capital (total assets − cash − non-interest-bearing current liabilities), so leverage cannot flatter it
roic (ratio table)
Quality · Cash margin
Cash profit kept from each dollar of sales
— Not reported
Wall Street
EBITDA margin
FY2024 — Not reported
negative: −0.6%
Value investor
Free-cash-flow margin
FY2024 2.6%
How it’s calculated
Wall Street · EBITDA margin
EBITDA ÷ revenue
ebitda ÷ revenue
Value investor · Free-cash-flow margin
(Operating cash flow − capital expenditures) ÷ revenue: taxes, interest, working capital and capex all paid
free cash flow ÷ revenue
Balance sheet · Liquidity
Short-term assets per dollar of bills due within a year
2.94×
Wall Street
Current ratio
FY2024 2.51×
1.57×
Value investor
Quick ratio, inventory excluded
FY2024 1.48×
Gap −1.37×: Value-investor figure 1.37 lower
How it’s calculated
Wall Street · Current ratio
Current assets ÷ current liabilities
current_ratio (ratio table)
Value investor · Quick ratio, inventory excluded
(Current assets − inventory) ÷ current liabilities
quick_ratio (ratio table)
Balance sheet · Debt cover
How many times one year of earnings repays all debt
— Not reported
Wall Street
EBITDA ÷ total debt
FY2024 — Not reported
negative: −0.03×
Value investor
FCF ÷ total debt
FY2024 0.12×
How it’s calculated
Wall Street · EBITDA ÷ total debt
EBITDA ÷ total debt (short-term + long-term)
ebitda ÷ total debt
Value investor · FCF ÷ total debt
Free cash flow ÷ total debt: what is actually left to repay it
free cash flow ÷ total debt
Each ratio measures one thing two ways, in the same unit: the popular formula, then a stricter one, so a lower figure is the stricter reading. Gap = value-investor figure minus Wall Street figure, from the figures shown.
Price-based ratios use the fiscal-year-end closing price. Free cash flow = operating cash flow − capital expenditures (we compute it; filings rarely report it). n/m = not meaningful (denominator ≤ 0); “—” = not reported. Each ratio’s formulas are under “How it’s calculated”.
Smart money
Showing the most recent 5 annual periods. Get longer history on the Pro plan, or the full history (1993–present) plus the smart-money dataset and webhooks on Institutional.
Peers, filings & research
Research Reports
No published research on NUE yet.
Reports appear here as analysts publish research on this company — built with Valuein's agentic workflows on data pinned to its SEC filing. Be the first: run equity_research_brief on NUE and publish the result to your public profile.
Cite this page
Data as of Nov 2, 2026. Canonical address: https://valuein.biz/data/NUE
Valuein. (2026, November 2). NUCOR CORP (NUE) financial statements, earnings power and smart-money summary [Data set]. Source: SEC EDGAR filings. https://valuein.biz/data/NUE
@misc{valuein_nue_2026,
author = {{Valuein}},
title = {NUCOR CORP (NUE) financial statements, earnings power and smart-money summary},
year = {2026},
howpublished = {\url{https://valuein.biz/data/NUE}},
note = {Data as of 2026-11-02; source: SEC EDGAR filings}
}10-K filed Feb 25, 2026 · accession 0001193125-26-071575
Agents: every figure Valuein's tools return carries a fact_id that traces to its SEC filing.
point-in-time · survivorship-free · every number traceable to its SEC filing
Index names are trademarks of their owners; Valuein is not affiliated with or endorsed by any index provider.